News &
Notifications
Home 9 Newsroom ( Page 9 )
Newsroom
Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network.
With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.
Here, you can go directly to the respective years of Investor Relations News:
All Categories
Global Corporate Leaders Leave Investors Blind on ESG
03.03.2021
In an elaborate study, cometis together with the market research institute KOHORTEN as well as currie comunications (AU) and Xenophon (US) examined 140 international companies with regard to their sustainability reporting.
March 1, 2021 SMT Scharf AG: FY 2020 operating result prospectively lower than expected
02.03.2021
SMT Scharf AG (German Securities Code (WKN) 575198, ISIN DE0005751986) announced that, as part of the preparation of the 2020 consolidated financial statements on the basis of preliminary figures, it has transpired that the operating result (EBIT) for the 2020 fiscal year is expected to amount to EUR -8.1 million (2019: EUR 6.8 million).
March 1, 2021 SMT Scharf AG: Revenue and earnings in 2020 significantly impacted by coronavirus and one-off effects
02.03.2021
SMT Scharf AG (WKN 575198, ISIN DE0005751986), one of the world’s leading suppliers of customised transport solutions and logistics systems for underground mining, reports revenue of EUR 50.2 million for the 2020 fiscal year on the basis of preliminary figures (2019: EUR 75.4 million).
EXCiPACT certification for c-LEcta’s high production standards
02.03.2021
Leipzig, March 2, 2021 – c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, can significantly reduce the cost of supplier audits for customers thanks to its recent award of EXCiPACT certification. The certificate confirms compliance with particularly high quality standards in production and distribution. For customers from the pharmaceutical industry in particular, these standards are an important criterion for qualifying suppliers and the closure of contracts. The certification significantly eases cooperation with new and existing customers for c-LEcta. EXCiPACT certification is internationally recognized and confirms that c-LEcta complies with “Good Manufacturing Practice” and “Good Distribution Practice” for pharmaceutical excipients.
February 25, 2021 SMT Scharf AG: Revocation of admission to the Regulated Market of the Frankfurt Stock Exchange
25.02.2021
SMT Scharf AG (German Securities Code (WKN) 575198, ISIN DE0005751986) has been informed as part of its downlisting from the Frankfurt Stock Exchange that the exchange has today published its decision to revoke the admission of the shares of SMT Scharf AG to trading on its Regulated Market and in its Prime Standard segment.
ESG: The pressure of NGOs on companies
19.02.2021
At least since the Fridays for Future demonstrations took place, it seems society is placing increasing importance on the protection of ...
- 4
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 5